WESTBURY, N.Y., March 21, 2014 /PRNewswire/ -- Vasomedical, Inc.
(OTC BB: VASO) announced today that it will release its financial
results for the three months ended and year ended December 31, 2013 on Thursday, March 27, 2014.
The Company will host a conference call on Thursday, March 27th at 10:00 a.m. ET featuring remarks by Jun Ma, Ph.D., President and CEO of Vasomedical,
and Michael Beecher, Chief Financial
Officer of Vasomedical. To dial into the conference call, please
dial 1-866-393-1344 from the U.S. or 1-631-291-4669,
internationally. All dial-in participants must use the following
code to access the call: 15577369. Please call at least five
minutes before the scheduled start time. The conference call will
also be available via webcast and can be accessed through the
Investor Relations section of Vasomedical's website,
www.vasomedical.com. Please allow extra time prior to the call to
visit the site and download any necessary software to listen to the
live broadcast.
A replay of the conference call will be available approximately
two hours after completion of the live conference call at
www.vasomedical.com. To access the dial-in replay of the call,
which will be available until April 28,
2014, please dial 1-855-859-2056 or 1-404-537-3406. All
dial-in participants must use the following code to access the
call: 15577369.
About Vasomedical
Vasomedical, Inc. is a diversified medical technology company
specializing in the manufacture and sale of medical devices and in
the domestic sale of diagnostic imaging products. The
Company's main proprietary products are EECP® Therapy
systems, the gold standard of ECP treatment. The Company operates
through three wholly owned subsidiaries: VasoSolutions, Vasomedical
Global and VasoHealthcare. VasoSolutions manages and coordinates
the design, manufacture and sales of EECP® Therapy systems, and
other medical equipment operations; Vasomedical Global operates the
Company's China-based
subsidiaries; and VasoHealthcare is the operating subsidiary for
the exclusive sales representation of GE Healthcare diagnostic
imaging products in certain market segments. Additional information
is available on the Company's website at www.vasomedical.com.
Investor Contacts:
Todd
Fromer / Garth Russell
KCSA Strategic Communications
212-896-1215 / 212-896-1250
tfromer@kcsa.com / grussell@kcsa.com
SOURCE Vasomedical, Inc.